| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 08/04/1999 | EP0932399A1 Water soluble paclitaxel prodrugs |
| 08/04/1999 | EP0932391A2 Fusogenic liposome composition and method |
| 08/04/1999 | EP0932390A1 Therapeutic liposome composition and method |
| 08/04/1999 | EP0759027B1 Bicyclic amidine derivatives as inhibitors of nitric oxide synthetase |
| 08/04/1999 | EP0752985B1 Hydrosoluble 3-arylidene-2-oxindole derivatives as tyrosine kinase inhibitors |
| 08/04/1999 | EP0740653B1 Hydroxamic acid derivatives as metalloproteinase inhibitors |
| 08/04/1999 | EP0628038B1 3-ALKYLOXY-, ARYLOXY-, OR ARYLALKYLOXYBENZO [b]THIOPHENE-2-CARBOXAMIDES AS INHIBITORS OF CELL ADHESION |
| 08/04/1999 | EP0567585B1 Hepatic growth factor receptor is the met proto-oncogene |
| 08/04/1999 | CN1225085A Substituted pyridines as selective cyclooxygenase-2 inhibitors |
| 08/04/1999 | CN1225009A Pentafluorobenzenesulfonamides and analogs |
| 08/04/1999 | CN1225007A Cationic virosomes as transfer system for genetic material |
| 08/04/1999 | CN1224718A Thiazole derivatives |
| 08/04/1999 | CN1224714A N-(4-carbamimido-phenyl)-phenylglycinamid derivatives |
| 08/04/1999 | CN1044476C Chelate and preparation thereof |
| 08/03/1999 | US5932742 Chemical intermediate to active antitumor agent |
| 08/03/1999 | US5932700 Efficient antitumor agent; diagnostic tool for detection of uterine tumors |
| 08/03/1999 | US5932694 Nucleic acid molecule encoding a bifunctional protein, the protein so encoded and uses thereof |
| 08/03/1999 | US5932616 Potent inducers of terminal differentiation and methods of use thereof |
| 08/03/1999 | US5932611 5-amino-2,2-dimethyl-6-(3'-(r,s) amino-4'-hydroxy-butan-1-one)-2,3-dihydro-4h-1-benzopyran-4-on e |
| 08/03/1999 | US5932609 Pharmaceutical composition for inhibiting the growth of cancers |
| 08/03/1999 | US5932604 Pharmaceutical compositions for the treatment of viral infections |
| 08/03/1999 | US5932598 Prodrugs of benzenesulfonamide-containing COX-2 inhibitors |
| 08/03/1999 | US5932595 Antiarthritic agent; multiple sclerosis; osteoporosis; respiratory system disorders; skin disorders; antiulcer agent |
| 08/03/1999 | US5932580 PDGF receptor kinase inhibitory compounds their preparation and compositions |
| 08/03/1999 | US5932565 Vitamin D analogues |
| 08/03/1999 | US5932560 Treatment of conditions and disease |
| 08/03/1999 | US5932555 Terpenoid compound 0406TP-1 |
| 08/03/1999 | US5932553 Illudin analogs useful as antitumor agents |
| 08/03/1999 | US5932547 Non-aqueous polar aprotic peptide formulations |
| 08/03/1999 | US5932471 DNA encoding chimeric toxin |
| 08/03/1999 | US5932442 Human regulatory molecules |
| 08/03/1999 | US5932425 Compositions and methods for modulating cellular NF-κB activation |
| 08/03/1999 | US5932248 Ionic polymer matrix |
| 08/03/1999 | US5932242 Anticarcinogenic agents, antiinflammatory agents |
| 08/03/1999 | US5932208 Compositions and methods for the use of such compositions in human therapeutics, characterized by the association of a muramyl peptide with a cytokine |
| 08/03/1999 | US5932189 Radiotherapy, radiodiagnosis peptides |
| 08/03/1999 | CA1340690C Semi-synthetic rhodomycins, a process for their preparation and their use as cytostatics |
| 07/30/1999 | CA2246001A1 Novel compounds |
| 07/29/1999 | WO1999037818A1 Novel molecules of the tnf receptor superfamily and uses therefor |
| 07/29/1999 | WO1999037797A1 Antigen-specific cells, methods of generating these cells and uses thereof |
| 07/29/1999 | WO1999037788A2 Diagnosis and treatment of aur1 and/or aur2 related disorders |
| 07/29/1999 | WO1999037753A1 Enzyme catalyzed therapeutic agents |
| 07/29/1999 | WO1999037751A1 Purified populations of stem cells |
| 07/29/1999 | WO1999037684A1 Antibodies to death receptor 4 (dr4) and uses thereof |
| 07/29/1999 | WO1999037683A1 MONOCLONAL ANTIBODY ANTI αv-INTEGRIN AND ITS USE TO INHIBIT αvβ6-INTEGRIN ATTACHMENT TO FIBRONECTIN |
| 07/29/1999 | WO1999037674A1 Secreted proteins and polynucleotides encoding them |
| 07/29/1999 | WO1999037669A1 PEPTIDES WITH β1 INTEGRIN SUBUNIT DEPENDENT CELL ADHESION MODULATING ACTIVITY |
| 07/29/1999 | WO1999037660A1 Meth1 and meth2 polynucleotides and polypeptides |
| 07/29/1999 | WO1999037653A1 New cytotoxic tris(oxazole)-containing macrolides |
| 07/29/1999 | WO1999037632A1 Alternate method for acylating 10-deacetylbaccatin iii selectively at the c-10 position |
| 07/29/1999 | WO1999037625A1 2,3,4,5-tetrahydro-1h-[1,4]-benzodiazepine-3-hydroxamic acids as matrix metalloproteinase inhibitors |
| 07/29/1999 | WO1999037621A1 Novel sulfonamide derivatives as inhibitors of bone resorption and as inhibitors of cell adhesion |
| 07/29/1999 | WO1999037322A1 Method of using il-11 to enhance cell mediated immunity for treating various viral and parasitic infections and cancer |
| 07/29/1999 | WO1999037314A1 Sea cucumber carotenoid lipid fraction products and methods of use |
| 07/29/1999 | WO1999037311A1 Cellulose derivatives and colorectal cancer risk reduction |
| 07/29/1999 | WO1999037304A1 SUBSTITUTED OXOAZAHETEROCYCLYL FACTOR Xa INHIBITORS |
| 07/29/1999 | WO1999037299A1 Use of inhibitors for the treatment of disorders related to rtk hyperfunction, especially cancer |
| 07/29/1999 | WO1999020755A3 Novel cytokine receptors |
| 07/29/1999 | WO1999012968A3 Chemokine peptides, variants, derivatives and analogs, their use in methods to inhibit or augment an inflammatory response |
| 07/29/1999 | WO1999012951A9 Uses of nicotinamide adenine dinucleotide and its analogs for treatment of malignant and infectious diseases |
| 07/29/1999 | WO1999002162A9 Cyclin dependent kinase inhibiting purine derivatives |
| 07/29/1999 | WO1998050530A3 Enzymatic nucleic acids: synthesis, selection and use |
| 07/29/1999 | CA2319207A1 Peptides with .beta.1 integrin subunit dependent cell adhesion modulating activity |
| 07/29/1999 | CA2319160A1 Monoclonal antibody anti .alpha.v-integrin and its use to inhibit .alpha.v.beta.6-integrin attachment to fibronectin |
| 07/29/1999 | CA2319121A1 Use of inhibitors for the treatment of rtk-hyperfunction-induced disorders, particularly cancer |
| 07/29/1999 | CA2319109A1 Meth1 and meth2 polynucleotides and polypeptides |
| 07/29/1999 | CA2318979A1 Antigen-specific cells, methods of generating these cells and uses thereof |
| 07/29/1999 | CA2318935A1 Phagocytosis genes and uses thereof |
| 07/29/1999 | CA2318743A1 Novel molecules of the tnf receptor superfamily and uses therefor |
| 07/29/1999 | CA2318405A1 Antibodies to death receptor 4(dr4) and uses thereof |
| 07/29/1999 | CA2318382A1 Method of using il-11 to enhance cell mediated immunity for treating various viral and parasitic infections and cancer |
| 07/29/1999 | CA2318352A1 Diagnosis and treatment of aur1 and/or aur2 related disorders |
| 07/29/1999 | CA2318303A1 Secreted proteins and polynucleotides encoding them |
| 07/29/1999 | CA2318221A1 Novel sulfonamide derivatives as inhibitors of bone resorption and as inhibitors of cell adhesion |
| 07/29/1999 | CA2317744A1 Cellulose derivatives and colorectal cancer risk reduction |
| 07/29/1999 | CA2317546A1 2,3,4,5-tetrahydro-1h-¬1,4|-benzodiazepine-3-hydroxamic acids as matrix metalloproteinase inhibitors |
| 07/29/1999 | CA2312350A1 Alternate method for acylating 10-deacetylbaccatin iii selectively at the c-10 position |
| 07/29/1999 | CA2311729A1 Purified populations of stem cells |
| 07/28/1999 | EP0931830A2 Cytopathic viruses for therapy and phophylaxis of neoplasia |
| 07/28/1999 | EP0931788A2 Metalloprotease inhibitors |
| 07/28/1999 | EP0931545A2 Droloxifene pharmaceutical compositions |
| 07/28/1999 | EP0931159A2 Non-mammalian dna virus having an altered coat protein |
| 07/28/1999 | EP0931157A1 Retroviral vectors |
| 07/28/1999 | EP0931156A2 Gene expression and delivery systems and uses |
| 07/28/1999 | EP0931147A1 ANTI-ErbB2 ANTIBODIES |
| 07/28/1999 | EP0931145A1 Ptx sensitive g proteins, the production and use thereof |
| 07/28/1999 | EP0931138A1 Method of producing a thymic microenvironment that supports the development of dendritic cells |
| 07/28/1999 | EP0931096A2 HT m4?, METHODS OF TREATMENT AND ASSAYS, AGONISTS AND ANTAGONISTS |
| 07/28/1999 | EP0931092A2 Variants of vascular endothelial cell growth factor having antagonistic properties |
| 07/28/1999 | EP0931083A1 Process for producing ecteinascidin compounds |
| 07/28/1999 | EP0931079A1 Substituted benzocycloheptapyridine derivatives useful for inhibition of farnesyl protein transferase |
| 07/28/1999 | EP0931078A1 Novel tricyclic piperidinyl compounds useful as inhibitors of farnesyl-protein transferase |
| 07/28/1999 | EP0931077A1 Substituted benzocycloheptapyridine useful as inhibitors of farnesyl-protein transferase |
| 07/28/1999 | EP0931075A1 Indazole derivatives and their use as inhibitors of phosphodiesterase (pde) type iv and the production of tumor necrosis factor (tnf) |
| 07/28/1999 | EP0931065A2 Nitric ester derivatives and their use in urinary incontinence and other diseases |
| 07/28/1999 | EP0931045A1 Matrix metalloproteinase inhibitors and their therapeutic uses |
| 07/28/1999 | EP0930892A1 Cytokine enhanced immunotherapy for brain tumors |
| 07/28/1999 | EP0930891A1 Oral administration of chicken yolk antibodies to treat disease |
| 07/28/1999 | EP0930887A2 Cancer immunotherapy using tumor cells combined with mixed lymphocytes |
| 07/28/1999 | EP0930886A1 Formulation for use in the prevention of pathogen induced diseases including hiv and hsv |